Fiasp® has a familiar profile that has been adjusted to increase the speed of initial insulin absorption.1
Fiasp® is designed for a fast onset of action1
Fiasp® is a formulation of insulin aspart with 2 excipients added1,2
The active molecule in Fiasp® is identical to NovoLog®.
The Fiasp® formulation contains the addition of niacinamide (vitamin B3) and a formulation-stabilizing amino acid (L-Arginine).2
Fiasp® has a fast onset of appearance1,3,a
Patient is an adult model and results shown are based on data from clinical studies and may not reflect patient experience.